Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. A Phase 3, Multicenter Randomized Double-blinded Controlled Against Placebo Study.

NCT07278661 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07278661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07278661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. A Phase 3, Multicenter Randomized Double-blinded Controlled Against Placebo Study.
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 16, 2026
Completion date
December 1, 2028
Enrollment
136 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chirurgical intervention, thrombocytopaenia